What triggers hair thinning during perimenopause?

Hair thinning during perimenopause is driven by a convergence of hormonal shifts and nutritional, physiological, and lifestyle factors. Identifying which are most relevant to your situation guides the most effective response, because the same visible symptom can have different primary drivers in different women.

The hormonal trigger is the changing estrogen-to-androgen ratio. Estrogen normally prolongs the anagen (growth) phase of the hair cycle, keeping more follicles actively growing at any given time. As estrogen declines, follicles spend less time in the growth phase and more time in the telogen (resting and shedding) phase, producing the diffuse reduction in hair density that many women notice. Simultaneously, the relative dominance of androgens increases as estrogen declines. Androgens, particularly dihydrotestosterone (DHT, converted from testosterone by the 5-alpha reductase enzyme), can miniaturize hair follicles on the scalp in genetically susceptible women. Miniaturized follicles produce progressively thinner, shorter, and lighter hairs over successive cycles, creating the diffuse thinning concentrated at the crown and top of the scalp (with the hairline generally preserved) that characterizes female androgenetic alopecia. Estrogen also indirectly counters androgen effects on follicles by increasing sex hormone binding globulin (SHBG), which binds free testosterone and reduces its conversion to DHT. As estrogen declines, SHBG falls, free testosterone rises, and DHT activity in the scalp increases.

Telogen effluvium from stress is a powerful and distinct trigger that operates through a separate mechanism. Chronic high cortisol from the multiple stressors of perimenopause (sleep deprivation, hormonal volatility, life demands) can push large numbers of hair follicles simultaneously into the telogen phase, producing dramatic shedding 2 to 3 months after the precipitating stress. This timing delay is why women often do not connect a significant shedding episode to its actual cause. A major illness, surgery, extreme dietary restriction, or a prolonged high-stress period can all trigger telogen effluvium in this way.

Iron deficiency is one of the most common and treatable causes of hair thinning in perimenopausal women, and it is frequently missed because providers check serum iron rather than ferritin (the stored iron measure). Hair follicles are among the most metabolically active tissues in the body and among the first to suffer when iron availability is reduced. The threshold ferritin level for optimal hair growth is generally considered to be above 70 micrograms per liter, which is above the standard laboratory normal range (typically 12 to 150). Many women are told their iron is normal when their ferritin is in the 20 to 40 range, which can still impair hair follicle function.

Zinc deficiency affects keratin synthesis (hair is made of the protein keratin) and can compound hormonal hair loss. Zinc is also involved in 5-alpha reductase activity regulation. Deficiency is worth testing rather than supplementing blindly, as excess zinc causes its own problems (copper deficiency, immune effects).

Biotin deficiency is frequently cited and heavily marketed for hair loss, but true biotin deficiency is uncommon, and supplementing without confirmed deficiency is unlikely to help. High-dose biotin supplementation can also interfere with thyroid hormone lab tests by causing false readings, which is particularly important when thyroid function is being evaluated alongside hair thinning.

Thyroid dysfunction, both hypothyroidism and hyperthyroidism, causes hair thinning that is clinically indistinguishable from hormonal hair loss. Hair follicles have thyroid hormone receptors and are highly sensitive to thyroid status. Thyroid testing should be standard in the evaluation of new-onset or worsening hair thinning during perimenopause. Subclinical hypothyroidism can produce hair loss without other obvious symptoms.

Protein deficiency reduces the substrate for keratin production. Inadequate protein intake (common in women who are under-eating, following very low-calorie diets, or emphasizing low-protein plant-based eating without careful planning) leads to thinner, more fragile hair and reduced growth rate.

Autoimmune conditions including alopecia areata, which causes patchy hair loss, and frontal fibrosing alopecia, which involves hairline recession with scalp scarring, can emerge or worsen during perimenopause as immune regulation changes. These have distinct appearances from hormonal thinning and require specific evaluation and treatment.

Tracking your symptoms over time using a tool like PeriPlan can help you identify whether hair thinning correlates with specific stress events, dietary changes, sleep patterns, or cycle phases.

When to talk to your doctor: Hair thinning that is rapid, patchy, involves eyebrows and body hair, is accompanied by fatigue, weight changes, skin changes, or temperature sensitivity warrants blood tests for thyroid function, iron stores (ferritin specifically), B12, and hormonal levels including DHT when appropriate. Early evaluation gives you more treatment options, including topical minoxidil, spironolactone, and targeted nutritional correction.

This content is for informational purposes only and does not replace medical advice. Always consult your healthcare provider about your specific situation.